Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1942 |  AUPH Aurinia Pharmaceuticals Inc - Common Shares | 16.31 USD | -2.04% | +6.05% | +5.43% | +36.71% | 2.17 B USD | ||
| 1949 |  ADMA ADMA Biologics Inc - Common Stock | 9.72 USD | -1.22% | +2.10% | +15.99% | -44.90% | 2.18 B USD | ||
| 1954 |  VCEL Vericel Corporation - Common Stock | 42.66 USD | -0.05% | -3.05% | -6.20% | +17.36% | 2.18 B USD | ||
| 1961 |  MESO Mesoblast Limited - American Depositary Shares | 16.44 USD | -3.29% | -3.92% | +9.75% | +2.75% | 2.10 B USD | ||
| 1978 |  NBTX Nanobiotix S.A. - ADSs | 39.72 USD | -8.79% | +0.28% | -0.10% | +321.66% | 1.92 B USD | ||
| 1979 |  ZBIO Zenas BioPharma, Inc. - Common Stock | 31.24 USD | -3.25% | +6.01% | +1.07% | +18.07% | 2.04 B USD | ||
| 1985 |  BHVN Biohaven Ltd. Common Shares | 13.74 USD | -0.79% | -4.45% | -6.78% | -18.89% | 2.08 B USD | ||
| 1987 |  STOK Stoke Therapeutics, Inc. - Common Stock | 31.75 USD | -1.67% | +1.37% | +7.34% | +62.49% | 2.05 B USD | ||
| 1991 |  XNCR Xencor, Inc. - Common Stock | 27.28 USD | -1.87% | +17.28% | +40.04% | +225.54% | 2.03 B USD | ||
| 2008 |  ZYME Zymeworks Inc. - Common Stock | 27.30 USD | -4.78% | +8.59% | +18.34% | +53.89% | 1.94 B USD | ||
| 2018 |  SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.19 USD | -3.19% | +0.94% | +10.44% | -10.13% | 1.92 B USD | ||
| 2020 |  TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.87 USD | -3.61% | -2.33% | +3.71% | +95.67% | 1.91 B USD | ||
| 2026 |  AGIO Agios Pharmaceuticals, Inc. - Common Stock | 33.07 USD | -0.06% | -0.87% | -8.72% | -23.78% | 1.97 B USD | ||
| 2045 |  IMCR Immunocore Holdings plc - American Depositary Shares | 36.04 USD | -2.28% | +5.91% | +2.80% | +7.65% | 1.86 B USD | ||
| 2054 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.30 USD | -5.71% | +6.11% | +8.55% | -34.00% | 1.77 B USD | ||
| 2057 |  SEPN Septerna, Inc. - Common Stock | 40.34 USD | +0.85% | -9.96% | +21.32% | +83.28% | 1.88 B USD | ||
| 2077 |  NTLA Intellia Therapeutics, Inc. - Common Stock | 12.40 USD | -3.43% | +4.20% | +12.01% | -9.62% | 1.74 B USD | ||
| 2098 |  GHRS GH Research PLC - Ordinary Shares | 27.45 USD | -3.11% | -6.41% | -1.47% | +93.86% | 1.70 B USD | ||
| 2099 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 19.26 USD | -1.98% | -2.28% | -8.68% | +18.45% | 1.72 B USD | ||
| 2103 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.27 USD | -0.65% | +4.70% | -6.36% | +119.06% | 1.74 B USD |
Nouvelles Biotechnology Stocks
Deutsche Bank dégrade argenx de Achat à Conserver en raison de la valorisation
Pourquoi l’action Monte Rosa Therapeutics chute-t-elle aujourd’hui ?
L’action Biomea Fusion bondit après la fin du recrutement pour son essai sur le diabète
L’action Monte Rosa chute au lancement d’une étude de phase 2 sur le cancer de la prostate
L’action Crinetics Pharmaceuticals atteint un record historique à 84,8 USD
H.C. Wainwright maintient sa recommandation sur Biomea Fusion après l’enrôlement
La FDA prolonge l’examen du deramiocel de Capricor au 22 novembre
Gainers Biotechnology Stocks
 SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
 RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
 ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
 NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
 OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
 LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
 BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
 CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
 HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
 CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
 RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
 ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
 APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
 BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
 YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
 SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |